로딩 중…
지수 로딩 중…
Damora Therapeutics Inc. Common Stock
DMRA· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$28.56-1.48%
2026-08-03
Financials
Valuation Metrics
Damora Therapeutics Inc. Common Stock's Market Cap is $1.76B. At end of 2025 it was $31M. Ranked #2148 of 3,112 in US market (top 69%), #837 of 1,445 on NASDAQ (top 58%), #151 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 56%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $1.76B | US#2,148/3,112 Sec#151/269 |
| Revenue | $0.00 | US#2,974/3,112 Sec#204/269 |
| Net Income | $-235M | US—/3,112 Sec—/269 |
| Total Assets | $535M | US#2,715/3,112 Sec#145/269 |
| Net Assets | $510M | US#2,249/3,112 Sec#113/269 |
| Value | ||
| P/B | 3.45x | US#1,828/3,112 Sec#107/269 |
| Profitability | ||
| ROE | -46.07% | US#2,724/3,112 Sec#167/269 |
| ROA | -43.91% | US#2,941/3,112 Sec#202/269 |
| Financial Health | ||
| Debt Ratio | 4.93% | US#47/3,112 Sec#18/269 |
| Total Debt | $1M | US#2,922/3,112 Sec#242/269 |
| Cash | $533M | US#1,037/3,112 Sec#53/269 |
| Current Ratio | 22.48x | US#113/3,112 Sec#26/269 |
| Performance | ||
| 1Y Return | 792.50% | US#4/3,112 Sec#2/269 |
| 1M Return | -4.74% | US#2,211/3,112 Sec#123/269 |
| From 52W High | -25.49% | US#1,971/3,112 Sec#140/269 |
| 1Y MDD | -72.38% | US#2,955/3,112 Sec#247/269 |
| Trading | ||
| Volume | 221,272 shares | US#2,599/3,112 Sec#250/269 |
| Trading Value | $6M | US#2,558/3,112 Sec#208/269 |